Send us Feedback

Biodel (BIOD)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Biodel (BIOD) files a $75 million mixed securities shelf
StreetInsider.com  May 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Biodel+%28BIOD%29+files+a+%2475+million+mixed+securities+shelf+/8333981.html for the full story.
Ladenburg Thalmann Upgrades Biodel (BIOD) to Buy
StreetInsider.com  May 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Ladenburg+Thalmann+Upgrades+Biodel+%28BIOD%29+to+Buy/8326951.html for the full story.
Biodel, Inc. (BIOD) Posts Q2 Loss of 37c/Share
StreetInsider.com  May 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Biodel%2C+Inc.+%28BIOD%29+Posts+Q2+Loss+of+37cShare/8315792.html for the full story.
Biodel, Inc. (BIOD) Reports Q1 Loss of $0.26
StreetInsider.com  Feb 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Biodel%2C+Inc.+%28BIOD%29+Reports+Q1+Loss+of+%240.26/8086978.html for the full story.
Benzinga's Small Cap Movers for Thursday January 24, 2013
Benzinga  Jan 25  Comment 
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: Biodel Shares of Biodel (NASDAQ: BIOD), the Danbury, CT specialty biopharmaceutical company, rose 13% Thursday on 24 times average...
Biodel Issues Correction on Earlier Release Related to BIOD-238, BIOD-250
Benzinga  Jan 24  Comment 
In a release issued earlier today by Biodel Inc. (Nasdaq: BIOD), one reference to BIOD-238 should have been BIOD-250 in the fourth paragraph. The corrected paragraph follows: Local injection site discomfort was measured with a 100 mm visual...
Biodel Reports Positive Top-Line Results from Phase 1 Clinical Trial of BIOD-238 and BIOD-250
Benzinga  Jan 24  Comment 
Biodel (NASDAQ: BIOD) today announced positive top-line results from a Phase 1 clinical trial of two ultra-rapid-acting insulin analog-based formulations, BIOD-238 and BIOD-250, conducted to evaluate the pharmacokinetic and injection site...
Biodel, Inc. (BIOD) Posts Q4 Loss of 42c/Share
StreetInsider.com  Dec 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Biodel%2C+Inc.+%28BIOD%29+Posts+Q4+Loss+of+42cShare/7954837.html for the full story.
Wedbush Securities Reiterates Neutral Rating, $3 PT on Biodel
Benzinga  Dec 7  Comment 
In a report published Friday, Wedbush Securities reiterated its Neutral rating and $3.00 price target on Biodel (NASDAQ: BIOD). Wedbush Securities noted, “We remain NEUTRAL on the stock with a $3 fair value. Despite being encouraged by the...
Biodel (BIOD) Gets Orphan Drug Designation for Glucagon
StreetInsider.com  Dec 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Biodel+%28BIOD%29+Gets+Orphan+Drug+Designation+for+Glucagon/7930343.html for the full story.




more ▼WIKI ANALYSIS
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800.
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Biodel_(BIOD)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki